Skip to content
naulon
Not checkedNot checked for notices yet.

Effects of Diagnosed Dementia on Medicare and Medicaid Program Costs

Padmaja Ayyagari, Martin Salm, Frank A. Sloan

Inquiry: The Journal of Health Care Organization, Provision, and Financing · 2007

doi:10.5034/inquiryjrnl_44.4.481 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

This study examines the impacts of physician-diagnosed Alzheimer's disease and related dementias (ADRD) on Medicare and Medicaid program costs in 1994 and 1999. An innovative method is employed to estimate program payments over the life cycle starting at age 65. Using data from the 1994 and 1999 National Long-Term Care Surveys, merged Medicare claims, and national program data for Medicaid, we find that the share of total Medicare and Medicaid payments attributable to diagnosed ADRD was 5.46% in 1999. Total annual program payments attributable to ADRD decreased between 1994 and 1999, in contrast to an increase implied by a cross-sectional approach.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.